Shu-ta Wu

Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma

Mahboubeh Yazdanifar, Ru Zhou, Priyanka Grover et al. · Cells · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +17

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

Shu-ta Wu, Anthony J. Fowler, Corey B. Garmon et al. · BMC Cancer · 2018 · 43 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Preclinical evaluation of an ¹¹¹In/²²⁵Ac theranostic targeting transformed MUC1 for triple negative breast cancer

Vanessa J. Kelly, Shu-ta Wu, Gottumukkala Vijay et al. · Theranostics · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors

Laura J. Moore, Lopamudra Das Roy, Ru Zhou et al. · Translational Oncology · 2016 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17

Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal Adenocarcinoma

Mahboubeh Yazdanifar, Ru Zhou, Priyanka Grover et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2019 · 22 citations · Full text

Life Sciences, Immunology, Oncology +17